Evidence map›Paper›PMID 34883281›Full record

ReviewJournal of autoimmunity2022

Ferritin - from iron, through inflammation and autoimmunity, to COVID-19.

Naim Mahroum, Amal Alghory, Zeynep Kiyak, Abdulkarim Alwani, Ravend Seida, Mahmoud Alrais, Yehuda Shoenfeld

Open access · greenAbstract readReview
In one paragraph

Review in Journal of autoimmunity, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 114 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
114citing papers in PubMed, 3 pooled it
20.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

114 citing papers in PubMed, 3 syntheses or guidelines pooled it, 190 citations in OpenAlex.

  1. Impact ofFrontiers in microbiology · 2025
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Targeted HAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

54 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Naim MahroumInternational School of Medicine, Istanbul Medipol University, Istanbul, Turkey; Internal Medicine B and Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Ramat- Gan, Israel; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel. Electronic address: naim.mahroum@gmail.com.
Amal AlghoryInternational School of Medicine, Istanbul Medipol University, Istanbul, Turkey.
Zeynep KiyakInternational School of Medicine, Istanbul Medipol University, Istanbul, Turkey.
Abdulkarim AlwaniInternational School of Medicine, Istanbul Medipol University, Istanbul, Turkey.
Ravend SeidaInternational School of Medicine, Istanbul Medipol University, Istanbul, Turkey.
Mahmoud AlraisInternational School of Medicine, Istanbul Medipol University, Istanbul, Turkey.
Yehuda ShoenfeldAriel University, Ariel, Israel.
Istanbul Medipol University · TRAriel University · ILTel Aviv University · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

While it took decades to arrive to a conclusion that ferritin is more than an indicator of iron storage level, it took a short period of time through the COVID-19 pandemic to wonder what the reason behind high levels of ferritin in patients with severe COVID-19 might be. Unsurprisingly, acute phase reactant was not a satisfactory explanation. Moreover, the behavior of ferritin in patients with severe COVID-19 and the subsequent high mortality rates in patients with high ferritin levels necessitated further investigations to understand the role of ferritin in the diseases. Ferritin was initially described to accompany various acute infections, both viral and bacterial, indicating an acute response to inflammation. However, with the introduction of the hyperferritinemic syndrome connecting four severe pathological conditions such as adult-onset Still's disease, macrophage activation syndrome, catastrophic antiphospholipid syndrome, and septic shock added another aspect of ferritin where it could have a pathogenetic role rather than an extremely elevated protein only. In fact, suggesting that COVID-19 is a new member in the spectrum of hyperferritinemic syndrome besides the four mentioned conditions could hopefully direct further search on the pathogenetic role of ferritin. Doubtlessly, improving our understanding of those aspects of ferritin would enormously contribute to better coping with severe diseases in terms of treatment and prevention of complications. The origin, history, importance, and the advances of searching the role of ferritin in various pathological and clinical processes are presented hereby in our article. In addition, the implications of ferritin in COVID-19 are addressed.

Indexed as

Acute-Phase ProteinsAutoimmune DiseasesCommunicable DiseasesCOVID-19FerritinsHumansHyperferritinemiaInflammationIronAcute-Phase ProteinsFerritinsIronAcute phase reactantCOVID-19FerritinHyperferritinemiaIron homeostasis

Identifiers

PMID34883281
PMCPMC8647584
OpenAlexW4200428208

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.